Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inotiv (NOTV)
NASDAQ:NOTV
Holding NOTV?
Track your performance easily
NOTV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.23 - $11.42
Previous Close$5.95
Volume1.18M
Average Volume (3M)510.14K
Market Cap
$154.79M
Enterprise Value$578.48M
Total Cash (Recent Filing)$21.43M
Total Debt (Recent Filing)$445.12M
Price to Earnings (P/E)―
Beta3.35
Next Earnings
Feb 13, 2025EPS Estimate
-$0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.19
Shares Outstanding26,015,129
10 Day Avg. Volume1,690,712
30 Day Avg. Volume510,142
Standard Deviation0.39
R-Squared0.24
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.91
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)-16.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.18
Enterprise Value/Gross Profit5.20
Enterprise Value/Ebitda-14.55
Forecast
1Y Price Target
$6.00Price Target Upside3.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Inotiv News
PremiumCompany Announcements
Inotiv, Inc. Faces Financial Turmoil: Going Concern Doubts and Debt Pressures
PremiumCompany Announcements
Inotiv, Inc. Announces Fiscal Year 2024 Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevenue of $130M exceeded the Street at $117M, and AEBITDA of $5.4M exceeded the Street at $1.7M.
Liquidity And Legal ResolutionNew debt facility and covenant reworking resolve near-term liquidity concerns, while legal issues are resolved, expected to relieve valuable human capital and reduce significant legal costs.
Stability And GrowthThe company is transitioning to a more contracted business, which is expected to reduce volatility in sales and margins, adding stability to the business.
Bears Say
Financial PerformanceThe company faced a sharp decline in EBITDA due to volatility in its largest acquisition and an overstocked customer channel.
Industry ChallengesDSA book-to-bill was 0.78x due to continued biotech spending headwinds.
Market PerformanceShares are well below prior year highs, mainly due to balance sheet concerns and unpredictable end markets.
---
Ownership Overview
10.30% Insiders
4.36% Mutual Funds
2.32% Other Institutional Investors
78.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NOTV FAQ
What was Inotiv’s price range in the past 12 months?
Inotiv lowest stock price was $1.23 and its highest was $11.42 in the past 12 months.
What is Inotiv’s market cap?
Currently, no data Available
When is Inotiv’s upcoming earnings report date?
Inotiv’s upcoming earnings report date is Feb 13, 2025 which is in 53 days.
How were Inotiv’s earnings last quarter?
Inotiv released its earnings results on Dec 03, 2024. The company reported -$0.73 earnings per share for the quarter, beating the consensus estimate of -$0.975 by $0.245.
Is Inotiv overvalued?
According to Wall Street analysts Inotiv’s price is currently Undervalued.
Does Inotiv pay dividends?
Inotiv does not currently pay dividends.
What is Inotiv’s EPS estimate?
Inotiv’s EPS estimate is -$0.8.
How many shares outstanding does Inotiv have?
Inotiv has 26,015,130 shares outstanding.
What happened to Inotiv’s price movement after its last earnings report?
Inotiv reported an EPS of -$0.73 in its last earnings report, beating expectations of -$0.975. Following the earnings report the stock price went down -6.205%.
Which hedge fund is a major shareholder of Inotiv?
Among the largest hedge funds holding Inotiv’s share is Graham Capital Management, L.P.. It holds Inotiv’s shares valued at N/A.
---
Inotiv Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (3.27% Upside)
$6.00 (3.27% Upside)
Blogger Sentiment
Bullish
NOTV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 34.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $628.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.1%
Last 30 Days ▲ 9.8%
Last 30 Days ▲ 9.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
115.57%
12-Months-Change
Fundamentals
Return on Equity
-49.33%
Trailing 12-Months
Asset Growth
-1.76%
Trailing 12-Months
Company Description
Inotiv
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
---
NOTV Earnings Call
Q4 2024
0:00 / 0:00
---
NOTV Stock 12 Month Forecast
Average Price Target
$6.00
▲(3.27% Upside)
Technical Analysis
Best Analysts Covering NOTV
1 Year
1 Year Success Rate
9/15 ratings generated profit
1 Year Average Return
+41.84%
assigned a buy rating 10 days ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +41.84% per trade.
---